D Chitayat

University of Toronto, Toronto, Ontario, Canada

Are you D Chitayat?

Claim your profile

Publications (103)420.28 Total impact

  • P. Glanc · E. Barkova · U. Mohan · A. Toi · S. Keating · D. Chitayat ·

    Ultrasound in Obstetrics and Gynecology 09/2015; 46(S1):50-51. DOI:10.1002/uog.15097 · 3.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: As treatment based genetic testing becomes a reality, it is important to assess the attitudes and preferences of women newly diagnosed with ovarian cancer regarding genetic testing. The objective of this study was to determine when women with a diagnosis of high grade serous ovarian cancer would prefer to undergo genetic testing and factors that influence this preference. Women over 18 years of age with a known diagnosis of high grade serous ovarian cancer diagnosed between October 2010-2013 were identified via the Princess Margaret Cancer Center Registry. Participants completed a questionnaire, which obtained preferences and attitudes towards genetic testing, cancer history, and demographic information. 120 of the 355 women identified (33.8%) completed the questionnaires. The median age at time of ovarian cancer diagnosis was 57 years (range 35-84). The majority of participants in this study were offered (94.6%) and pursued (84.8%) genetic testing. In this cohort, testing was most frequently offered at diagnosis (41.8%) or during treatment (19.1%). In this study, women with high grade serous ovarian cancer felt genetic testing should be offered before or at the time of diagnosis (67.8%). Having a family history of breast or ovarian cancer was significantly (p=0.012) associated with preferring genetic testing at an earlier time point in the disease course. Our results demonstrate that women with high grade serous ovarian cancer acknowledge the personal and clinical utility of genetic testing and support test implementation at the time of cancer diagnosis. Copyright © 2015. Published by Elsevier Inc.
    Gynecologic Oncology 04/2015; 137(3). DOI:10.1016/j.ygyno.2015.03.057 · 3.77 Impact Factor

  • 19th International Congress of the World-Muscle-Society; 10/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Robinow Syndrome (RS), a rare skeletal dysplasia syndrome, is characterized by dysmorphic features resembling a fetal face, mesomelic limb shortening, hypoplastic external genitalia in males, and renal and vertebral anomalies. Both autosomal dominant and autosomal recessive patterns of inheritance have been reported. Since the description of autosomal dominant Robinow Syndrome (ADRS; OMIM 180700) in 1969 by Meinhard Robinow and colleagues, the molecular etiology remained elusive until only recently. WNT5A was proposed to be the candidate gene for ADRS, as mutations were found in two affected families, one of those being the originally described index family. We report three families with RS caused by novel heterozygous WNT5A mutations, which were confirmed in the first family by whole exome sequencing, and in all by Sanger sequencing. To our knowledge, this is the largest number of published families with ADRS in whom a WNT5A mutation was identified. Families 1 and 2 are the first cases showing de novo inheritance in the affected family members and thus strengthen the evidence for WNT5A as the causative gene in ADRS. Finally, we propose WNT5A mutation specificity in ADRS, which may affect interactions with other proteins in the Wnt pathway.
    Clinical Genetics 04/2014; 87(1). DOI:10.1111/cge.12401 · 3.93 Impact Factor
  • Aiyar L · Davies J · Hayeems RZ · Velsher L · Aw J · Pu S · Wodak S · Chitayat D · Shuman C ·

    Genetics in Medicine 03/2014; 16(3):231-237. · 7.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cornelia de Lange syndrome (CdLS) is characterized by distinct facial features, growth retardation, upper limb reduction defects, hirsutism, and intellectual disability. NIPBL mutations have been identified in approximately 60% of patients with CdLS diagnosed postnatally. Prenatal ultrasound findings include upper limb reduction defects, intrauterine growth restriction (IUGR), and micrognathia. CdLS has also been associated with decreased PAPP-A and increased nuchal translucency (NT). We reviewed NIPBL sequence analysis results for 12 prenatal samples in our laboratory to determine the frequency of mutations in our cohort. This retrospective study analyzed data from all 12 prenatal cases with suspected CdLS which were received by The University of Chicago Genetic Services laboratory. Diagnostic NIPBL sequencing was performed for all samples. Clinical information was collected from referring physicians. NIPBL mutations were identified in 9 out of the 12 cases prenatally (75%). Amongst the NIPBL mutation-positive cases with clinical information available, the most common findings were upper limb malformations and micrognathia. Five patients had NT measurements in the first trimester, of which four were noted to be increased. We demonstrate that prenatally-detected phenotypes of CdLS, particularly severe micrognathia and bilateral upper limb defects,are associated with an increased frequency of NIPBL mutations. This article is protected by copyright. All rights reserved.
    Prenatal Diagnosis 02/2014; 34(2). DOI:10.1002/pd.4279 · 3.27 Impact Factor
  • Source
    A. J. Robinson · S. I. Blaser · A. Toi · D. Chitayat · S. Pantazi · W. Halliday · G. Ryan ·

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and purpose: Diffusion-weighted imaging can be used to characterize brain maturation. MR imaging of the fetus is used in cases of suspected Chiari II malformation when further evaluation of the posterior fossa is required. We sought to investigate whether there were any quantitative ADC abnormalities of the cerebellum in fetuses with this malformation. Materials and methods: Measurements from ROIs acquired in each cerebellar hemisphere and the pons were obtained from calculated ADC maps performed on our Avanto 1.5T imaging system. Values in groups of patients with Chiari II malformations were compared with those from fetuses with structurally normal brains, allowing for the dependent variable of GA by using linear regression analysis. Results: There were 8 fetuses with Chiari II malformations and 23 healthy fetuses, ranging from 20 to 31 GW. There was a significant linear decline in the cerebellar ADC values with advancing gestation in our healthy fetus group, as expected. The ADC values of the cerebellum of fetuses with Chiari II malformation were higher [1820 (±100) × 10⁻⁶ mm²/s] than ADC values in the healthy fetuses (1370 ± 70) × 10⁻⁶ mm²/s. This was statistically significant, even when allowing for the dependent variable of GA (P = .0126). There was no significant difference between the pons ADC values in these groups (P = .645). Conclusions: While abnormal white matter organization or early cerebellar degeneration could potentially contribute to our findings, the most plausible explanation pertains to abnormalities of CSF drainage in the posterior fossa, with increased extracellular water possibly accounting for this phenomenon.
    American Journal of Neuroradiology 05/2013; 34(8). DOI:10.3174/ajnr.A3468 · 3.59 Impact Factor
  • M. P. Kava · P. Ray · D. Chitayat · L. McAdam · S. Blaser · J. Vajsar ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in the FKRP gene account for a broad spectrum of patients ranging from CMD to a much milder LGMD2I. The involvement of the eyes can be variable with most patients having normal eye examination. We describe eye abnormalities in a child with Walker–Warburg phenotype due to a novel FKRP gene mutation in exon 3 and compare these with other reported cases with FKRP mutation. A boy was born to a G6P3L2 woman from Ghana. The couple was non-consanguineous and a previous pregnancy was interrupted for occipital encephalocele. Antenatal ultrasound showed severe hydrocephalus and delivery was by caesarian section at term. He had hypotonia, bilateral elbow contractures and very limited spontaneous movements. His creatine kinase was 6664 IU/L. Brain MRI showed massive hydrocephalus, diffuse cobblestone lissencephaly, hypomyelination, cerebellar cortical dysplasia, hypoplastic pons and deformed brainstem with fusion of colliculi. Eye examination revealed right micropthalmia, nonreactive pupils, absent red reflex, very deep anterior chamber with retrolental fibrovascular tissue. B scan showed closed funnel and total retinal unattachment. The left eye had shallow anterior chamber, tunica vasculosa lentis and clear lens, persistent vascular membrane, hypoplastic optic nerve, retinal pigmentary epithelium and vitreous hemorrhage. Fluorescein angiography revealed large areas of capillary dropouts and non perfusion ischemic retina. DNA testing showed two mutations in the FKRP gene: Exon 3:c.558dupC (p.Ala187fs) and Exon 3:c.1418T>G (p.Phe473cys).Patients with FKRP gene mutation have no or mild eye involvement (strabismus) with very few cases reported with moderate to severe eye involvement. Our patient represents one of the most severe phenotypes described in regards to eye involvement.
    Neuromuscular Disorders 10/2012; 22(s 9–10):815. DOI:10.1016/j.nmd.2012.06.046 · 2.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: In recent years, there has been an expansion in research focused on uncovering the underlying biological and genetic causes of autism. This research depends on the willingness of families with autism to participate; thus, there is a duty to ensure that participants’ needs are met throughout this process. Objectives: The purpose of this study is to explore families’ motivations for participating in genetic research for autism, and the expectations that participants place on actual or hypothetical genetic information. In doing so, we hope to inform researchers about participants’ needs and concerns, and to gauge whether or not their expectations are in line with those of researchers and are being met. Methods: We utilized a qualitative approach to explore participants’ experiences with genetic research for autism. We conducted semi-structured interviews with 9 parents who have one or more children with autism enrolled in genetic research through the Autism Research Unit at the Hospital for Sick Children in Toronto, Canada. Sampling was purposeful for variability across four dimensions: 1) Long-standing versus recent involvement in genetic research, 2) one versus more children with ASD in the family, 3) severity of the diagnosis on the autism spectrum, and 4) whether or not families have received genetic results from the research study. Respondents also completed a validated questionnaire that gauges tolerance for ambiguity as a general personality trait. Ambiguity may have particular relevance for individuals participating in genetic research since results can be marked with vague, inconsistent, incomplete, probable, or unclear meanings and prognoses. Results: Motives for participating were classified as benefitting ‘self’ or ‘others’, although these were not mutually exclusive. Interestingly, while respondents discussed their interest in obtaining a genetic research result, they also valued aspects of participation that were distinct from this. Information in general helped maximize certainty and provided a sense of control over their current situation. A pattern emerged where the values placed on the act of participating in genetic research for autism were distinct from the values placed on having genetic information. The former was seen as beneficial for forming a connection with autism experts, networking with other families with autism and providing hope, while the latter alleviates feelings of guilt, raises awareness and validates the medical nature of autism. A separate area of discussion was respondents’ expectations of how they would to be able to use genetic information. With advances in technology, this has evolved from being simply informative to hoping to tailor interventions to an individual child’s genetic ‘brand’ of autism and for family planning purposes. Conclusions: The results of this study highlight the complex factors involved in the decision to participate in genetic research for autism and the value of genetic information. It provides points to consider in order to ensure that research participants are treated respectfully, that their expectations are addressed properly, and that their needs for care throughout this process are met.
    2012 International Meeting for Autism Research; 05/2012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chromosomal band 1q21.1 can be divided into two distinct regions, proximal and distal, based on segmental duplications that mediate recurrent rearrangements. Microdeletions and microduplications of the distal region within 1q21.1, which are susceptibility factors for a variety of neurodevelopmental phenotypes, have been more extensively studied than proximal microdeletions and microduplications. Proximal microdeletions are known as a susceptibility factor for thrombocytopenia-absent radius (TAR) syndrome, but it is unclear if these proximal microdeletions have other phenotypic consequences. Therefore, to elucidate the clinical significance of rearrangements of the proximal 1q21.1 region, we evaluated the phenotypes in patients identified with 1q21.1 rearrangements after referral for clinical microarray testing. We report clinical information for 55 probands with copy number variations (CNVs) involving proximal 1q21.1: 22 microdeletions and 20 reciprocal microduplications limited to proximal 1q21.1 and 13 microdeletions that include both the proximal and distal regions. Six individuals with proximal microdeletions have TAR syndrome. Three individuals with proximal microdeletions and two individuals with larger microdeletions of proximal and distal 1q21.1 have a 'partial' TAR phenotype. Furthermore, one subject with TAR syndrome has a smaller, atypical deletion, narrowing the critical deletion region for the syndrome. Otherwise, phenotypic features varied among individuals with these microdeletions and microduplications. The recurrent, proximal 1q21.1 microduplications are enriched in our population undergoing genetic testing compared with control populations. Therefore, CNVs in proximal 1q21.1 can be a contributing factor for the development of abnormal phenotypes in some carriers.
    European journal of human genetics: EJHG 02/2012; 20(7):754-61. DOI:10.1038/ejhg.2012.6 · 4.35 Impact Factor
  • Source
    K. Fong · S. Blaser · J. Drake · D. Chitayat ·

    Ultrasound in Obstetrics and Gynecology 10/2011; 38(S1). DOI:10.1002/uog.9648 · 3.85 Impact Factor
  • Source
    E. Howse · T. Teoh · E. Kelly · D. Chitayat · P. McParland · G. Ryan ·

    Ultrasound in Obstetrics and Gynecology 10/2011; 38(S1). DOI:10.1002/uog.9863 · 3.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Congenital megalourethra is a rare urogenital malformation characterized by dilation and elongation of the penile urethra associated with absence or hypoplasia of the corpora spongiosa and cavernosa. Postnatal complications include voiding and erectile dysfunction as well as renal insufficiency and pulmonary hypoplasia. To date, only a few prenatally diagnosed cases have been reported. We report on 10 cases diagnosed prenatally and their postnatal/autopsy findings. The study involved retrospective chart review of all cases diagnosed antenatally in three tertiary care centers over 5 years. Antenatal ultrasound images and medical records from obstetrics, genetics, urology and nephrology were reviewed. Ten fetuses with megalourethra were identified at a median gestational age of 19 (range, 13-24) weeks and all were confirmed postnatally or at autopsy. Three pregnancies were terminated and seven continued. All cases presented with a distended bladder and megalourethra and all cases had normal karyotype. Of seven liveborn babies, one died neonatally of pulmonary hypoplasia. All six infants alive at the time of writing had a dysfunctional urethra and three suffered from impaired or end-stage renal disease. Associated anomalies were found in half of the cases. Congenital megalourethra is caused by abnormal development or hypoplasia of the penile erectile tissue, secondary to distal urethral obstruction. When the amniotic fluid volume is normal, survival is possible. However, all liveborn infants have voiding and renal dysfunction and sexual dysfunction is expected. Megalourethra should be considered in all male fetuses presenting prenatally with megacystis and detailed fetal ultrasonography should look for an elongated and/or distended phallic structure as well as any associated anomalies.
    Ultrasound in Obstetrics and Gynecology 06/2011; 37(6):678-83. DOI:10.1002/uog.8862 · 3.85 Impact Factor
  • Source
    A Toi · K Fong · D Chitayat · P Shannon · S Blaser ·

    Ultrasound in Obstetrics and Gynecology 10/2010; 36(S1):24. DOI:10.1002/uog.7840 · 3.85 Impact Factor

  • Ultrasound in Obstetrics and Gynecology 10/2010; · 3.85 Impact Factor
  • Source
    H Y B Chung · T Uster-Friedberg · S Pentaz · S Blaser · K Murphy · D Chitayat ·

    Ultrasound in Obstetrics and Gynecology 10/2010; 36(4):521-2. DOI:10.1002/uog.7731 · 3.85 Impact Factor
  • E J T Winsor · H Akoury · D Chitayat · L Steele · T L Stockley ·
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective was to determine the risk of sampling error in amniocentesis and chorionic villus sampling (CVS) in singleton and multiple pregnancies. Data from this and other published studies were used to discuss current practice guidelines for molecular identity testing. Clinical and laboratory records of all patients undergoing molecular-based identity testing in our clinical laboratory from July 2002 until March 2008 were reviewed. DNA microsatellite testing was performed to determine zygosity in multiple pregnancies and maternal cell contamination (MCC) in both singleton and multiple pregnancies. MCC was detected in 6/148 (4%) CVS and 1/87 (1%) amniotic fluids from singleton pregnancies. In two of the CVS, only maternal cells were found. In 2/24 (8%) twin pregnancies, the same fetus was tested twice. In a total of 285 pregnancies (235 singleton, 24 twin, 26 with >or= 3 fetuses), without molecular identity testing, four women would have received erroneous results. Current guidelines recommend molecular identity testing for MCC in conjunction with molecular diagnostic testing, but not for cytogenetic testing. No published guidelines were found for zygosity testing in multiple pregnancies. We suggest that identity testing be considered for all prenatal testing of multiple pregnancies, especially if CVS is performed.
    Prenatal Diagnosis 08/2010; 30(8):746-52. DOI:10.1002/pd.2530 · 3.27 Impact Factor
  • Source
    H Y B Chung · L Chu · C Forrest · R Silver · A Toi · S Blaser · S Viero · G Taylor · D Chitayat ·
    [Show abstract] [Hide abstract]
    ABSTRACT: No Abstracts.
    Ultrasound in Obstetrics and Gynecology 07/2010; 36(1):121-4. DOI:10.1002/uog.7624 · 3.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ciliary disorders share typical features, such as polydactyly, renal and biliary cystic dysplasia, and retinitis pigmentosa, which often overlap across diagnostic entities. We report on two siblings of consanguineous parents and two unrelated children, both of unrelated parents, with co-occurrence of Joubert syndrome and Jeune asphyxiating thoracic dystrophy, an association that adds to the observation of common final patterns of malformations in ciliary disorders. Using homozygosity mapping in the siblings, we were able to exclude all known genes/loci for both syndromes except for INVS, AHI1, and three genes from the previously described Jeune locus at 15q13. No pathogenic variants were found in these genes by direct sequencing. In the third child reported, sequencing of RPGRIP1L, ARL13B, AHI1, TMEM67, OFD1, CC2D2A, and deletion analysis of NPHP1 showed no mutations. Although this study failed to identify a mutation in the patients tested, the co-occurrence of Joubert and Jeune syndromes is likely to represent a distinct entity caused by mutations in a yet to be discovered gene. The mechanisms by which certain organ systems are affected more than others in the spectrum of ciliary diseases remain largely unknown.
    American Journal of Medical Genetics Part A 06/2010; 152A(6):1411-9. DOI:10.1002/ajmg.a.33416 · 2.16 Impact Factor

Publication Stats

2k Citations
420.28 Total Impact Points


  • 1994-2015
    • University of Toronto
      • • Department of Obstetrics and Gynaecology
      • • Hospital for Sick Children
      • • Department of Laboratory Medicine and Pathobiology
      Toronto, Ontario, Canada
  • 2005-2014
    • Mount Sinai Hospital, Toronto
      Toronto, Ontario, Canada
  • 1994-2012
    • SickKids
      • • Division of Clinical and Metabolic Genetics
      • • Department of Paediatrics
      • • Division of Clinical Pharmacology and Toxicology
      Toronto, Ontario, Canada
  • 2009
    • National Human Genome Research Institute
      Maryland, United States
  • 2003-2007
    • Mount Sinai Hospital
      New York City, New York, United States
  • 1995-2001
    • UHN: Toronto General Hospital
      Toronto, Ontario, Canada
  • 2000
    • Women's College Hospital
      Toronto, Ontario, Canada
  • 1998
    • Montreal Heart Institute
      Montréal, Quebec, Canada